Biosimilars
Your Professional Biosimilars Manufacturers
Suzhou Biosynergy Pharmaceutical Co., Ltd. was established in 2014, headquartered in Suzhou Industrial Park. It is a professional company engaged in the research and development, production, and sales of Biosimilars, APIs and intermediates. In the process of rapid development, the company has always followed the management philosophy of "integrity, professionalism, and innovation",
-
Adalimumab Rheumatoid Arthritis Ankylosing SpondylitisEnglish name:Adalimumab for arthritisread more
CAS number:331731-18-1
English synonym:
Adalimumab;D2E7;Humira;Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal... -
Aflibercept Diabetic Macular EdemaEnglish name:Aflibercept diabetic macular edemaread more
CAS number:845771-78-0
English synonym:
AFLIBERCEPT;Eylea;9: PN: US20050043236SEQID: 10 unclaiMed protein... -
Study Of Alirocumab for HypercholesterolemiaEnglish name:The cholesterol drug Alirocumabread more
CAS number:1245916-14-6
English synonym:
Alirocumab;REGN 727;SAR 236553;Research Grade Alirocumab(DHJ24001);Research Grade... -
Atezolizumab Monoclonal Antibodies for Cancer ResearchEnglish name:Atezolizumab cancer drugread more
CAS number:1380723-44-3
Atezolizumab; MPDL3280A; Atezolizumab (anti-PD-L1); Research Grade Atezolizumab(DHJ70101);... -
Bevacizumab Monoclonal AntibodyEnglish name:Bevacizumab monoclonal antibodyread more
CAS number:216974-75-3
English... -
Cetuximab Is An Antitumor DrugEnglish name:Cetuximab is an antitumor drugread more
CAS number:205923-56-4
English... -
Daratumumab Monoclonal Antibody Prevents Multiple MyelomaEnglish name:Daratumumab monoclonal antibodyread more
CAS number:945721-28-8
English synonym:Daratumumab; Daratumumab - 20mg/ml in water; Daratumumab 21.7mg/ml; Daratumumab USP/EP/BP;... -
Denosumab Human Monoclonal Antibodies Have Anticancer Act...English name:Denosumab monoclonal antibodyread more
CAS number:615258-40-7
English synonym:D03684;D03684;Denosumab;Denosumab (usan);AMG 162;IMMunoglobulin G2, anti-(huMan osteoclast... -
Dulaglutide Is A Glucagon-like Peptide-1 Receptor AgonistEnglish name:Dulaglutideread more
CAS number:923950-08-7
Another name:Dulaglutide - solution in PBS;Dulaglutide USP/EP/BP;Dulaglutide;Research Grade Dulaglutide(DHE40129);Research Grade... -
Eculizumab Is A Monoclonal AntibodyEnglish name:Eculizumabread more
CAS number:219685-50-4
Another name:
... -
Evolocumab Monoclonal Antibody PCSK9 InhibitorEnglish name:Evolocumabread more
CAS number:1256937-27-5
Another name:Evolocumab;AMG 145;Research Grade Evolocumab(DHJ24002);AMG-145,Ser/Thr Protease,Repatha,AMG 145,inhibit,atherosclerotic... -
Infliximab Is A Chimeric Monoclonal IgG1 AntibodyEnglish name:Infliximabread more
CAS number:170277-31-3
Another name:
Avakine; Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal ca2 heavy chain),...
Why Choose Us
Our Factory
Biosynergy has an 84000 square meter biopharmaceutical research and production workshop in Changshu, Jiangsu, mainly producing monoclonal antibodies. Biosynergy has established research and development centers of over 1000 square meters in Nantong, Jiangsu and Jinan, Shandong, with a production site of 13500 square meters.
Various Products
Our advantageous products include monoclonal antibodies, ADC small molecule toxins, various fermented pharmaceutical raw materials and intermediates.
Production Market
Biosynergy has cooperated with many customers from India, Russia, Bangladesh, Vietnam, Pakistan, Türkiye, Saudi Arabia, Iran, Belarus, Egypt, etc.
Our Certificates
Under the strict management of IS09001 quality system, the company's products have passed a series of international standard certificates such as GMP, CE, FDA, ROHS, LFGB and so on.
Cetuximab is mainly effective by inhibiting cell proliferation, promoting cell apoptosis, and inhibiting blood vessel formation and metastasis:
By increasing the expression of cell cycle inhibitor p27kip, cells to stay in G1 phase, and cells decline in the S phase, thus inhibiting cell proliferation.
Induced tumor cell apoptosis by increasing Bax expression and decreasing bcl-2 expression, with bcl-2 being the apoptosis inhibitory gene and Bax being the apoptosis-promoting gene.
Reduce proangiogenic factors such as TGF- α, Chemicalbook bidirectional regulator, cripto and other tumor cell secreted growth factor and vascular endothelial growth factor VE GF, basal fibroblast growth factor bF GF, and interleukin-8 (IL-8) related to microvascular proliferation, inhibit tumor blood vessel formation and reduce the number of microvessels.
Cetuximab also inhibits tumor cell invasion and metastasis, which may be related to inhibiting the expression and activity of molecules (such as matrix metalloproteinase-9) that play a key role in tumor cell adhesion.

Usage and Dosage of Cetuximab Is An Antitumor Drug

It is recommended that EGFR be tested in experienced laboratories according to the validated method; cetuximab alone must be administered under the guidance of a physician with experience with anticancer drugs. The condition of the patient must be closely monitored and must be equipped with resuscitation equipment. Before the first infusion of the product, the patient must receive antihistamine therapy, and Chemicalbook agreed before each subsequent use of the product. This product was administered once a week. The initial measurement is 400mg / m2 surface area, and then 250mg / m2 body surface area per week. For initial administration, the recommended infusion time is 120 minutes and 60 minutes for subsequent weekly administration, and the maximum infusion rate shall not exceed 5 ml/min.
Product Description of Cetuximab Is An Antitumor Drug
|
Product Name |
Cetuximab |
|
Synonyms |
|
|
Morphological |
Liquid |
|
CAS |
205923-56-4 |
|
Appearance |
WHITE |
|
Molecular Formula |
C107H179N35O36S7 |
|
Molecular Weight |
2756.23406 |
|
Assay |
>99% |
|
Application |
For research purpose only |
|
Storage |
Store in a well-closed,light-resistant container |
|
Remarks |
NA |
|
Custom synthesis |
Available |
Pharmacological properties of Bevacizumab Monoclonal Antibody
The estimated half life (a measure of drug action duration) of bevacizumab is approximately 20 days and the time taken for the drug to reach a steady-state concentration in the blood is around 100 days. The volume of distribution is 46 mL/kg and the drug is eliminated from the body at a rate of 2.75 to 5 mL/kg/day, depending on factors such as body weight, gender and extent or size of the tumor.
Apply of Bevacizumab Monoclonal Antibody
Used in the clinical treatment of tumors, such as in the treatment of psoriasis.
For the first-line treatment of patients with advanced colorectal cancer
For colon cancer and can also be used for breast cancer and lung Chemicalbook cancer. Overview, pharmacological effects, indications, adverse reactions, etc.
Product Specifications of Bevacizumab Monoclonal Antibody
|
Product Name |
Bevacizumab monoclonal antibody |
|
Class |
Monoclonal |
|
Type |
Antibody |
|
CAS number: |
216974-75-3 |
|
Molecular formula: |
C6638H10160N1720O2108S44 |
|
Einecs number: |
200-160-3 |
|
Related: |
Drug substance; mab 5; drug substance and intermediates; chemical reagent |
|
Morphological : |
Liquid |
|
Color: |
Colourless to light yellow |
|
Condition of storage: |
Store at -80°C |
|
Solubility: |
Dissolved in dimethyl sulfoxide |
|
Shipping conditions |
Ambient (domestic); Wet ice (international) |
Packaging and Transportation


As one of the leading biosimilars suppliers in China, we warmly welcome you to wholesale bulk biosimilars in stock here from our factory. Good service and quality products are available.
331731-18-1, The cholesterol drug Alirocumab, Daratumumab monoclonal antibody